Candidate Biosimilar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Candidate Biosimilar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Candidate Biosimilar Today - Breaking & Trending Today

CT-P43 Shows Equivalent Efficacy, Safety for Plaque Psoriasis vs Ustekinumab

Published: November 29, 2023

Data from a phase 3 trial of CT-P43 in patients with moderate to severe plaque psoriasis offers additional insight into the comparative effects of the biosimilar relative to ustekinumab.

Source: hcplive.com

Related Topics:

South KoreaRepublic Of KoreaKim PappProbity Medical Research IncEuropean Medicines AgencyDrug AdministrationArcutis TherapeuticsEuropean Union SourcedPsoriasis AreaSeverity IndexGlobal AssessmentCandidate BiosimilarOriginator UstekinumabIsevere Plaque PsoriasisWeek Results